Ascendis Pharma
ASND
ASND
92 hedge funds and large institutions have $2.49B invested in Ascendis Pharma in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7.93% more ownership
Funds ownership: 83.9% → 91.83% (+7.9%)
8% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 25
Holders
92
Holding in Top 10
14
Calls
–
Puts
–
Top Buyers
| 1 | +$155M | |
| 2 | +$84.2M | |
| 3 | +$64.3M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$44.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$36.4M |
Top Sellers
| 1 | -$87.6M | |
| 2 | -$34.5M | |
| 3 | -$20M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.6M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$7.19M |